Technical Forum: Small-Molecule Synthesis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Technical Forum: Small-Molecule Synthesis
Pharmaceutical Technology gains insight into approaches for producing aromatic amines.


Pharmaceutical Technology
Volume 34, Issue 9, pp. 48-50

References

1. R.N. Salvatore, C. H. Yoon, and K.W. Jung, Tetrahedron 57 (10) 7785–7811 (2001).

2. Y. Watanabe et al., Tetrahedron Lett. 22 (28), 2667–2670 (1981).

3. Y. Watanabe et al., J. Org. Chem. 49 (18), 3359–3363 (1984).

4. Y. Watanabe et al., J. Org. Chem. 61 (13), 4214–4218 (1996).

5. C. Jun et al., Chem. Commun. 13, 1405–1406 (1998).

6. R.A.T.M. Abbenhuis, J. Boersma, and G. van Koten, J. Org. Chem. 63 (13), 4282–4290 (1998).

7 T. Naota, H. Takaya, and S.I. Murahashi, Chem. Rev. 98 (7), 2599–2660 (1998).

8. R. Grigg et al. J. Chem. Soc. Chem. Commun. 12, 611–612 (1981).

9. G. Cami Kobeci, and J.M. Williams. J. Chem. Soc. Commun., 1072–1073 (2004).

10. K.I. Fujita and R. Yamaguchi, Synlett. 4, 560–571 (2005).

11. R. Yamaguchi et al., Org. Lett. 10 (2) 181–184 (2008).

12. D. Hollmann et al., Angew. Chem. Int. Ed. 46 (43), 8291–8294 (2007).

13. A. Tillack et al., Tetrahedron Lett. 47 (50), 8881–8885 (2006).

14. K. Fujita, Y. Enoki, and R. Yamaguchi, Tetrahedron 64 (8), 1943–1954 (2008).

15. M.H Hamid et al., J. Am. Chem. Soc. 131 (5), 1766–1774 (2009).

16. T.E. Müller and M. Beller, Chem. Rev. 98 (2), 675–704 (1998).

17. M. Beller et al., Chem. Eur. J. 5 (4), 1306–1319 (1999).

18. M. Nobis and B. Driessen-Hölscher, Angew. Chem., Int. Ed. 40 (21), 3983–3985 (2001).

19. M. Utsunomiya et al., J. Am. Chem. Soc. 125 (19), 5608–5609 (2003).

20. J.S. Ryu, G.Y. Li, and T.J.J. Marks, J. Am. Chem. Soc. 125 (19), 12584–12605 (2003).

21. A.M. Johns et al., J. Am. Chem. Soc. 128 (6) 1828–1839 (2006).

22. D. Chan et al., Tetrahedron Lett. 39 (19), 2933–2936 (1998).

23. D.A. Evans, J.L. Katz, and T.R. West, Tetrahedron Lett. 39 (19) 2937–2940 (1998).

24. P.Y.S. Lam, et al., Tetrahedron Lett. 39 (19) 2941–2944 (1998).

25. P.Y.S. Lam et al., Synlett. 5, 674–676 (2000).

26. J.P. Collman and M. Zhong, Org. Lett. 2 (9), 1233–1236 (2000).

27. J.C. Antilla and S.L. Buchwald, Org. Lett. 3 (13), 2077–2079 (2001).

28. P.Y.S. Lam et al., Tetrahedron Lett. 42 (20), 3415–3453 (2001).

29. C. Moessner and C. Bolm, Org. Lett. 7 (13), 2667–2669 (2005).

30. J.B. Lan et al., Synlett. 6, 1095–1097 (2004).

31. B. Sreedhar et al., Synthesis 5, 795–799 (2008).

32. T. Tsuritaniet et al., Org. Lett. 10 (8), 1653–1665 (2008).

33. S. Bérnard, L. Neuville, and J. Zhu, J. Org. Chem. 73 (16) 6441–6444 (2008).

34. Boronic Acids, D.G. Hall, Ed., (1st Edition, Wiley-VCH, Weinheim, Germany, 2005).

35. I. González et al., Org. Lett. 11 (8) 1677–1680 (2009).

36. M. Larrosa et al., Synlett., 14, 2101–2105, (2010).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
25%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
36%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here